Therefore, CD146 is important in PEM resistance in NSCLC brain metastases and may be a therapeutic target to overcome chemoresistance and high CD146 expression in cases with refractory NSCLC brain metastases. Here, MCAM is linked to non-small cell lung carcinoma.